Download Files:
Lp-PLA2-IN-13
SKU
HY-153559-Get quote
Category Reference compound
Tags Metabolic Enzyme/Protease, Neurological Disease, Phospholipase
Products Details
Product Description
– Lp-PLA2-IN-13 (compound 15) is a potent Lp-PLA2 inhibitor. Lp-PLA2-IN-13 has the potential for the research of neurodegenerative related diseases[1].
Web ID
– HY-153559
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C22H17F5N4O4
References
– [1]ZhengHua Gu, et al. Tricyclic pyrimidone compounds, preparation method, composition and application thereof. CN113861220A.
CAS Number
– 2756855-62-4
Molecular Weight
– 496.39
Compound Purity
– 99.95
SMILES
– O=C1N=C(C2=C(N1CCC3)N3CCO2)OCC4=CC(F)=C(C(F)=C4)OC5=CC(C(F)(F)F)=NC=C5
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– 10 mM in DMSO
Target
– Phospholipase
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.